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SUMMARY
Since the first generation of induced pluripotent stem cells (iPSCs), several reprogramming systems have been used to study its
molecular mechanisms. However, the system of choice largely affects the reprogramming efficiency, influencing our view on the
mechanisms. Here, we demonstrate that reprogramming triggered by less efficient polycistronic reprogramming cassettes not only
highlights mesenchymal-to-epithelial transition (MET) as a roadblock but also faces more severe difficulties to attain a pluripotent state
even post-MET. In contrast, more efficient cassettes can reprogram both wild-type and Nanog/ fibroblasts with comparable effi-
ciencies, routes, and kinetics, unlike the less efficient reprogramming systems. Moreover, we attribute a previously reported variation
in the N terminus of KLF4 as a dominant factor underlying these critical differences. Our data establish that some reprogramming
roadblocks are system dependent, highlighting the need to pursue mechanistic studies with close attention to the systems to better
understand reprogramming.
INTRODUCTION
Ever since the first generation of induced pluripotent
stem cells (iPSCs) using retroviral vectors for Oct4, Sox2,
Klf4, and c-Myc (O, S, K, and M, respectively) (Takahashi
and Yamanaka, 2006), many researchers have focused
on understanding the reprogramming mechanism for a
more efficient and rapid generation of iPSCs. To this
end, it is essential to understand the molecular roadmaps
toward successful reprogramming, to identify bottle-
necks, and to develop strategies to overcome these obsta-
cles. Recently, a few detailed reprogramming roadmaps
have been described from time course gene expression
analyses as well as cell-surface-marker-based reprogram-
ming intermediate subpopulation analyses (Hussein
et al., 2014; O’Malley et al., 2013; Polo et al., 2012). In
this context, we have reported that monitoring expres-
sion changes of CD44, ICAM1, and a Nanog-GFP reporter
enables the tracking of the successful progression of re-
programming using a 2A-peptide-linked MKOS polycis-
tronic reprogramming cassette (M-K-O-S in this order)
(O’Malley et al., 2013). Reprogramming intermediates
isolated based on their CD44/ICAM1/Nanog-GFP profile
demonstrated an increasing probability to reach a plurip-
otent state concordant with the stage of progression
defined by the markers. However, whether the roadmaps
change when different reprogramming systems that have
distinct reprogramming efficiencies are used has not been
addressed yet.
Reduction of heterogeneity during reprogramming is
critical for revealing molecular roadmaps and precise
mechanistic analysis. In this regard, the use of 2A
peptides constituted a significant improvement (Carey
et al., 2009; Kaji et al., 2009; Okita et al., 2008; Sommer
et al., 2009; Yusa et al., 2009). Polycistronic cassettes
carrying all four factors linked with 2A peptides have
simplified the reprogramming procedure and established
a consistent reprogramming factor stoichiometry. On
the other hand, it has also been shown that the use of
distinct polycistronic vectors could result in different
reprogramming efficiencies (Okita et al., 2008). This
suggests that reprogramming with different polycistronic
cassettes, which may have distinct stoichiometry and/
or expression levels of the Yamanaka factors, could
face various degrees and/or kinds of roadblocks during
reprogramming.
Reprogramming in the absence of Nanog is one example
where cells face a significant roadblock and/or deviate
from the original route. Nanog belongs to the core
transcription factors of the pluripotency transcription
network and has been shown to be important for mainte-
nance and induction of pluripotency (Chambers et al.,
2003; Mitsui et al., 2003; Silva et al., 2009). Recent studies
have shown that Nanog null mouse embryonic fibroblasts
(MEFs) can give rise to iPSCs only in the presence of
Vitamin C (VitC) (Schwarz et al., 2014) or with 100-fold
less efficiency compared to wild-type (WT) MEFs in the
absence of VitC (Carter et al., 2014). Nevertheless, Nanog
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is still largely considered important for iPSC generation,
and it has not been addressed yet whether the Nanog/
cells that fail to become iPSCs halt at a certain point
of the reprogramming route or divert to a different cell
state.
Taking advantage of a cell surface marker profiling sys-
tem and efficiently reprogrammable MEFs, we investi-
gated reprogramming routes and roadblocks using several
polycistronic cassettes and Nanog/ MEFs. We demon-
strate that the pattern of cell surface marker changes is
different when reprogramming cassettes with distinct re-
programming efficiencies are used. The majority of re-
programming intermediates derived using a less efficient
reprogramming cassette is trapped in partially reprog-
rammed states, concealing the route that the few iPSCs
followed. On the contrary, efficient reprogramming cas-
settes can reprogram even Nanog/ MEFs with efficiency,
routes, and kinetics comparable to those of WT MEFs.
Therefore, we highlight the necessity to take into consid-
eration the reprogramming system when mechanistic an-
alyses are performed.
RESULTS
Polycistronic Cassettes with Distinct Reprogramming
Phenotypes
Several polycistronic cassettes carrying the four Yamanaka
factors have been used for the generation of iPSCs. We
previously performed a detailed analysis of MKOS-induced
reprogramming routes using CD44 and ICAM1 cell surface
markers in combination with a gene-targeted Nanog-GFP
reporter (O’Malley et al., 2013). Carey et al. (2011) demon-
strated that iPSC lines derived with the OSKM cassette
tend to have better chimera contribution when injected
into blastocysts than those derived with the STEMCCA
(OKSM) cassette in the absence of VitC. Thus, we per-
formed piggyBac (PB)-transposon-mediated reprogram-
ming with the aforementioned MKOS, OSKM, and
STEMCCA cassettes to compare their potentials to give
rise to iPSC colonies (Figure 1A). We also included the
OKMS cassette in our analysis (Kim et al., 2015), generated
from the OKS cassette that showed the highest repro-
gramming efficiency among other polycistronic cassettes
Figure 1. PB Reprogramming with Different Polycistronic Cassettes
(A) Structures of PB transposons carrying different polycistronic cassettes used in this study.
(B) Numbers of Nanog-GFP+/ colonies 15 days after reprogramming using the PB MKOS, OSKM, STEMCCA, or OKMS transposons. Error bars
represent SD; n = 3 independent experiments.
(C) CD44, ICAM1, and Nanog-GFP expression changes in PB reprogramming with the MKOS or OKMS cassette. Red indicates Nanog-GFP,
and green indicates Nanog-GFP+. Gates 1, 2, and 3 indicate ICAM1low/CD44high, ICAM1low/CD44low, and ICAM1high/CD44low, respectively, as
indicated in the right panel.
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containing three reprogramming factors, Oct4, Sox2, and
Klf4 (Okita et al., 2008). Indeed, the OKMS cassette gave
rise to a much larger number of colonies with an embry-
onic stem cell (ESC)-like morphology when compared to
the other constructs (Figure 1B). However, these colonies
displayed limited activation of the Nanog-GFP reporter,
suggesting that cells inmost of the colonies were facing sig-
nificant obstacles in reaching a fully pluripotent state
(Figure 1B). The high proportion of Nanog-GFP partially
reprogrammed colonies was also observed when the
STEMCCA cassette was used, albeit to a lesser extent (Fig-
ure 1B). Most of the colonies in both MKOS and OSKM
reprogramming, which previously demonstrated similar
CD44 and ICAM1 expression changes (O’Malley et al.,
2013), had become Nanog-GFP+ by day 15 (Figure 1B). We
decided to focus on the comparison between MKOS and
OKMS cassettes, given that they displayed themost striking
differences in Nanog-GFP activation. Further differences
stood out when we analyzed CD44, ICAM1, and Nanog-
GFP expression changes during PB-mediated reprogram-
ming (Figure 1C). As previously shown (O’Malley et al.,
2013), reprogramming with MKOS demonstrated clear
stepwise changes in CD44 and ICAM1 expression. In
particular, we observed loss of the ICAM1high population
(gate 1 in Figure 1C, days 6–10) and downregulation of
CD44 (gate 2 in Figure 1C, days 8–10), followed by the
regain of ICAM1 expression (gate 3 in Figure 1C, days 8–
14) accompanied by Nanog-GFP induction. In contrast,
OKMS reprogramming displayed a very distinct flow cy-
tometry profile. The majority of cells had already downre-
gulated CD44 by day 6, without any clear change in
ICAM1 expression, while some cells remained CD44/
ICAM1 double-positive even on day 14 (Figure 1C). Finally,
Nanog-GFP+ cells appeared only in the CD44lowICAM1high
gate (gate 3 in Figure 1C) where ESCs and fully reprog-
rammed iPSCs are found, in contrast to MKOS reprogram-
ming in which some cells had gained Nanog-GFP expres-
sion before reaching gate 3 (day 10 and day 12 in
Figure 1C) (O’Malley et al., 2013). These data suggest that
reprogramming systems that allow expansion of partially
reprogrammed cells demonstrate distinct CD44/ICAM1
expression changes.
MKOS/OKMSTransgenicMEFReprogramming System
For a more precise comparison between MKOS and OKMS
reprogramming, we generated a transgenic (Tg) MEF re-
programming system using all-in-one gene targeting vec-
tors with doxycycline-inducible reprogramming factors
(Figure 2A). In the previously reported reprogrammable
MEF/mouse systems, either the Col1a1 or the Rosa26 locus
was used to insert the OSKM or STEMCCA reprogramming
cassette (Carey et al., 2010; Haenebalcke et al., 2013; Stadt-
feld et al., 2010). The Col1a1 systems require reverse tetra-
cycline-controlled transactivator (rtTA) expression from
another locus such as the Rosa26 locus; therefore, two
rounds of gene targeting are necessary (Carey et al., 2010;
Stadtfeld et al., 2010). WhenMEFs from the Rosa26 system
carry both the reprogramming and an rtTA cassette at the
same locus, transgene induction occurred only in 9% (het-
erozygous) or 15% (homozygous) of MEFs, indicating that
the Rosa26 locus is not optimal for placement of the doxy-
cycline-inducible transgenes (Haenebalcke et al., 2013). In
our system, a vector carrying a doxycycline-inducible
MKOS or OKMS reprogramming cassette along with a
CAG-promoter (chicken b-actin promoter with cytomega-
lovirus [CMV] enhancer)-driven rtTA cassette was targeted
into the third intron of the Sp3 gene of the TNG ESC line,
which contains a Nanog-GFP reporter (Chambers et al.,
2007), resulting in TNG MKOS or TNG OKMS ESCs. The
Sp3 locus was identified in an iPSC line with a single inte-
gration of the PB MKOS reprogramming transposon,
D6s4B5, previously used for efficient secondary reprogram-
ming (O’Malley et al., 2013). TNG MKOS or TNG OKMS
ESCs were used to generate chimeric embryos, from which
Tg MEFs (TNG MKOS or TNG OKMS MEFs) were prepared.
Tg MEFs could be identified by culturing cells in the pres-
ence of doxycycline, resulting in the expression of anmOr-
ange reporter linked to the reprogramming cassettes with
an ires sequence (imO; Figure 2A). Similarly to the PB
MKOS reprogramming, almost all the colonies from TNG
MKOS MEFs had gained robust Nanog-GFP expression by
day 12 (Figures 2B–2D). In contrast, TNG OKMS MEFs
showed increased proliferation of Tg cells and gave rise to
more ESC-like colonies. However, these colonies bore het-
erogeneous activation of the Nanog-GFP reporter (Figures
2B–2E), consistent with the previously observed PB reprog-
ramming phenotype using OKMS cassettes (Figure 1B).
Importantly, Nanog-GFP+ cell lines established from both
TNG MKOS and TNG OKMS reprogramming could con-
tribute to live chimeras (Figure 2F), demonstrating that
both MKOS and OKMS systems could generate bona fide
iPSCs.
OKMS Reprogramming-Specific Roadblocks
In order to characterize the intermediate subpopulations
during MKOS and OKMS reprogramming, we analyzed
the expression changes of E-cadherin (E-CAD; also known
as CDH1), CD44, ICAM1, andNanog-GFP with flow cytom-
etry (Figures 3A and 3B). E-CAD is a hallmark of mesen-
chymal-to-epithelial transition (MET) that is an essential
step in the early stage of reprogramming from MEFs to
iPSCs. Factors that facilitate MET have been reported to
enhance reprogramming efficiency (Samavarchi-Tehrani
et al., 2010; Li et al., 2010). As we previously reported
(O’Malley et al., 2013),90% of cells undergoingMKOS re-
programmingwere E-CAD+ by day 5, indicating thatMET is
352 Stem Cell Reports j Vol. 5 j 350–364 j September 8, 2015 j ª2015 The Authors
not a major barrier in MKOS reprogramming (Figures 3A
and 3B, upper panels). In contrast, during OKMS reprog-
ramming, only about 45% of Nanog-GFP/mOrange+ cells
expressed E-CAD even on day 10, highlighting that the dif-
ficulty to go throughMET during reprogramming is system
dependent (Figures 3A and 3B, bottom panels). Next, we
aimed to compare how the pre- and post-MET populations
progress toward an iPSC state in MKOS and OKMS reprog-
ramming. For this purpose, we sorted E-CAD+/ Nanog-
GFP reprogramming intermediates from the CD44low
ICAM1low (2NG) and CD44lowICAM1high (3NG) gates
on day 10 (Figure S1A) and plated them in reprogramming
Figure 2. TNG MKOS/OKMS MEF Reprogramming System
(A) The Sp3 locus targeting scheme and Southern blot analysis. The green boxes represent Sp3 exons 1–4 from the right side. The red
triangle in the third intron indicates the PB transposon integration site identified in the D6s4B5 iPSC line. SacI/SphI double-genome
digestion yielded WT 15 kb and targeted 10-kb fragments detected by the probe indicated as a red bar. pA, poly(A) signal.
(B) Number of Nanog-GFP+/GFP colonies on day 15 of TNG MKOS/OKMS reprogramming. Error bars represent SD; n = 3 independent
experiments.
(C) Whole-well merged images of mOrange (red) and Nanog-GFP (green) on day 15 of TNG MKOS/OKMS reprogramming. Scale bar, 7 mm.
(D) Tracking images of a typical TNG MKOS or OKMS reprogramming colony from days 5 to 15. Scale bar, 500 mm.
(E) Tg cell numbers during TNG MKOS/OKMS reprogramming. Error bars represent SD; n = 3 independent experiments.
(F) Chimeric mice generated with TNG MKOS or OKMS iPSC lines.
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Figure 3. Inefficient Reprogramming Progression of OKMS Reprogramming Intermediates
(A) E-CAD and Nanog-GFP expression changes during TNG MKOS/OKMS reprogramming. Red indicates E-CAD Nanog-GFP, white indicates
E-CAD+ Nanog-GFP, and green indicates E-CAD+ Nanog-GFP+.
(B) CD44 and ICAM1 expression changes during TNG MKOS/OKMS reprogramming with E-CAD, Nanog-GFP expression color codes in (A).
(C) Flow cytometry analysis of sorted day-10 E-CAD/+ 2NG (Nanog-GFP CD44 ICAM1), 3NG (Nanog-GFP CD44 ICAM1+), and 3NG+
(Nanog-GFP+ CD44 ICAM1+) cells after a 24-hr culture. dox, doxycycline.
(D) E-CAD/+ 2NG, 3NG, and 3NG+ (Nanog-GFP+ CD44 ICAM1+) cells on day 10 were seeded at clonal density, and Nanog-GFP+ iPSC
colonies were counted after 10 days of further culture. The graph depicts the relative Nanog-GFP+ CFA compared to that of MKOS 3NG+ cells.
Error bars represent SD; n = 3 independent experiments.
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conditions. E-CAD populations, which were abundant
only in OKMS reprogramming, had gained neither
E-CAD nor Nanog-GFP expression 24 hr after sorting (Fig-
ure 3C). Both MKOS and OKMS E-CAD+ 2NG cells pro-
gressed to the 3NG gate in a similar manner. However,
OKMS 3NG cells produced only 2.5% Nanog-GFP+ cells
24 hr after sorting, whereas their MKOS counterparts
yielded 21.9% Nanog-GFP+ cells (Figure 3C). Even 72 hr af-
ter sorting, only 14% Nanog-GFP+ cells were observed from
the OKMS E-CAD+ 3NG population (Figure S1B). Accord-
ingly, pre- or post-MET 2NG and 3NG cells sorted from
OKMS reprogramming hardly formed any iPSC colonies
when seeded at clonal density and cultured for a further
10 days in reprogramming conditions (Figure 3D). On the
other hand, their MKOS counterparts demonstrated
increasing colony formation ability (CFA) from the 2NG
to the 3NG stage (Figure 3D) (O’Malley et al., 2013). Simi-
larly, OKMS intermediates sorted on day 8 of reprogram-
ming had reduced CFA, indicating that the majority of
them had lower potential to form iPSCs, regardless of the
timing of the analysis (Figure S1C). However, even in
OKMS reprogramming, Nanog-GFP+ cells from the CD44lo-
wICAM1high gate (3NG+ cells) had increased CFA, reaching
about 60% of the MKOS 3NG+ cells (Figure 3D). These data
indicate that intermediate populations from MKOS and
OKMS reprogramming, even with the same E-CAD,
CD44, and ICAM1 expression patterns, had very distinct
probabilities to progress toward iPSCs before gaining
Nanog-GFP expression. It is likely that the majority of
OKMS intermediates face more severe challenges than
MKOS intermediates, and only very few cells can reach a
pluripotent state.
RNA-Sequencing Analysis of MKOS/OKMS
Reprogramming Intermediates
To further characterize the 2NG and 3NG intermediate
populations in MKOS/OKMS reprogramming, we per-
formed RNA-sequencing analysis including WT/MKOS/
OKMS MEFs, 3NG+ cells, and doxycycline-independent
iPSCs from MKOS/OKMS reprogramming, as well as WT,
TNG, and TNGMKOS/OKMS ESCs. Hierarchical clustering
(average of replicates, all genes) revealed four major
branches: (1) MEFs; (2) TNG OKMS E-CAD+/, 2NG, and
3NG; (3) TNG MKOS E-CAD+, 2NG, and 3NG; and (4)
TNG MKOS/OKMS 3NG+, iPSCs, and ESCs (Figure 4A).
Principal-component analysis (PCA) with all genes clearly
showed that MKOS reprogramming intermediates (2NG
and 3NG) were distinct from E-CAD+ and from E-CAD
2NG and 3NG cells inOKMS reprogramming (Figure 4B),
in agreement with their different CFAs (Figure 3D). In
contrast to the Nanog-GFP intermediates and consistent
with the increased colony formation efficiency, OKMS
Nanog-GFP+ (3NG+) cells clustered together with MKOS
3NG+ as well as iPSCs and ESCs (Figure 4B). Next, we iden-
tified differentially expressed genes (DEGs; false discovery
rate % 0.05) by comparing neighboring samples of the
MKOS and OKMS reprogramming samples, respectively,
and assigned each DEG to one of five groups (A–E) with
distinct expression dynamics as defined by k-means clus-
tering (Figure 4C). Most of the DEGs in MKOS and OKMS
reprogramming overlap (6,126 of a total 7,291 DEGs in
MKOS and 7,418 DEGs in OKMS), and their distribution
into the five categories was also similar (Figure 4D). How-
ever, there were three large groups of genes that displayed
different dynamics between MKOS and OKMS: (1) DEGs
that displayed delayed downregulation in the OKMS re-
programming, i.e., 28.7% (435) of MKOS class A DEGs
(1,514) overlapped with OKMS class B DEGs (MA_OB
DEGs); (2) DEGs that had delayed downregulation in the
MKOS reprogramming, i.e., 25.4% (579) of MKOS class B
DEGs (2278) overlapped with OKMS class A DEGs
(MB_OA DEGs); and, finally, (3) DEGs that displayed de-
layed upregulation in the OKMS reprogramming, i.e.,
32.6% (612) of MKOS class D DEGs (1,873) overlapped
with OKMS class E DEGs (MD_OE DEGs). Names of all
DEGs in MKOS or OKMS reprogramming and the cross-
overlapping DEGs are shown in Table S1. The most en-
riched gene ontology (GO) terms in the cross-classified
MA_OB DEGs were ‘‘regulation of transcription’’ and
‘‘pattern specification process,’’ with Benjamini FDRs of
7.5 3 103 and 6.5 3 103, respectively (Benjamini and
Hochberg, 1995). Genes with these GO terms include
Hoxa2,Hoxb5,Hoxc10, andHoxd10, and these genes associ-
ated with body pattern formation were downregulated
more rapidly in MKOS reprogramming (Figure S2; Table
S1). GO terms with the highest enrichment in MA_OB
DEGs were ‘‘actin binding’’ and ‘‘cytoskeletal protein bind-
ing’’ (both with Benjamini 1.4 3 1011). Genes with these
highly enriched GO terms includes Aif1l, Cap1, Capg,
Capzb, Cnn1, Myo1c, and Myo1d and were, indeed, more
slowly downregulated inMKOS reprogramming (Figure S2;
Table S1). It was surprising that downregulation of some
genes occurred more slowly in the more efficient MKOS re-
programming system. Roles of these genes in reprogram-
ming might be worth investigating in the future. MD_OE
DEGs were rich in genes with GO terms associated with
cell cycles and transcription, including multiple pluripo-
tency genes (Figure S2; Table S1). Gene expression scatter-
plots revealed that many of these transcription factors
were differentially expressed (>1.5-fold) in the 2NG and
3NG intermediate subpopulations, suggesting a potential
contribution to the distinct probability to form iPSC col-
onies (Figure 4E). Interestingly, both the PCA and the heat-
map demonstrated that MKOS 3NG+ cells still maintained
some characters of 3NG cells, but OKMS 3NG+ cells were
very distinct from 3NG cells and almost indistinguishable
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Figure 4. Distinct Gene Expression Profiles of MKOS/OKMS Reprogramming Intermediates
(A) Hierarchical clustering of replicate averages with all genes.
(B) PCA. Red or blue dots represent cells with MKOS or OKMS cassettes, respectively. Black dots represent cells without the reprogramming
cassettes.
(C) Expression heatmaps of MKOS/OKMS reprogramming with hierarchical clustering using DEGs, which were grouped to five clusters with
distinct expression dynamics.
(D) A chord diagram demonstrating three cross-classified DEG groups between MKOS A and OKMS B (MA_OB), MKOS B and OKMS A (MB_OA),
and MKOS D and OKMS E (MD_OE).
(E) Whole-transcriptome scatterplots highlighting the pluripotency genes (upper panels) and other transcription regulators (lower panels)
identified in the MD_OE DEGs. The gray diagonal lines represent 1.5-fold differences in the expression levels.
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from iPSCs/ESCs (Figures 4B and 4C). These data indicated
that the majority of OKMS 3NG cells were trapped in a
partially reprogrammed state, and the transition to a fully
reprogrammed state was difficult to track in the OKMS re-
programming system. It is not clear whether the few suc-
cessfully reprogrammed OKMS 3NG+ cells came sporadi-
cally from the trapped state or whether a very small
number of cells in OKMS reprogramming experienced
gene expression changes as in MKOS reprogramming.
Our analyses highlight the importance of characterizing
the efficiency of cellular state transitions in conjunction
with gene expression profiling when investigating reprog-
ramming routes.
The N-Terminal Nine Amino Acids of Klf4 in the
Polycistronic Reprogramming Cassettes Determine
the Marker Expression Changes
While thismanuscript was under revision, Kim et al. (2015)
reported that the currently available polycistronic reprog-
ramming cassettes containing four Yamanaka factors can
be classified into two groups: those carrying a long Klf4
(Klf4L, currently annotated as full length) or those carrying
a shortKlf4 (Klf4S,missing the nineN-terminal amino acids
of Klf4L) (Figure S3A). Interestingly, Klf4S produced less
protein compared to Klf4L when used in the polycistronic
cassettes (Figure S3B) (Kim et al., 2015). The polycistronic
reprogramming cassettes containing Klf4S, such as OKMS,
had lower reprogramming efficiency, which could be
rescued by replacing Klf4S with Klf4L (OK
+9MS) (Kim
et al., 2015). Thus, we investigated whether the aforemen-
tioned differences in the expression patterns of E-CAD,
CD44, and ICAM1 were also due to the difference in Klf4.
Strikingly, reprogramming with OK+9MS and STEMCCA+9,
carrying the Klf4L, demonstrated expression changes of all
those markers, as well as Nanog-GFP, similar to those of
MKOS reprogramming (Figures 5A and 5B). Recently, Nish-
imura et al. (2014) demonstrated that reducing the amount
of KLF4 using a drug-inducible protein stabilization system
resulted in the generation of partially reprogrammed cells
trapped at different stages of reprogramming. In addition,
Klf4 is involved in promoting MET (Li et al., 2010). Our
data demonstrate that clear stepwise CD44 and ICAM1
expression changes during reprogramming are also associ-
ated with the robust expression of Klf4.
Lack of Nanog Does Not Constitute a Roadblock in
MKOS Reprogramming
CD44 and ICAM1 markers revealed distinct molecular sig-
natures between MKOS and OKMS reprogramming inter-
mediates. Thus, we decided to further apply this marker
analysis where significant roadblocks or route deviations
were expected; namely, Nanog/ MEF reprogramming.
Nanog has been reported to be essential for the generation
of iPSCs (Silva et al., 2009), and overexpression of Nanog
along with the Yamanaka factors increased efficiency and
accelerated kinetics of reprogramming (Hanna et al.,
2009). Two groups have recently reported the successful
generation of Nanog/ iPSCs. However, reprogramming
of the Nanog null MEFs either was 100-fold less efficient
than WT MEFs (Carter et al., 2014) or required the inclu-
sion of VitC in the reprogramming conditions (Schwarz
et al., 2014). Taken together, these results suggested that
the absence ofNanog presents a significant reprogramming
roadblock.
To elucidate reprogramming barriers associated to Nanog
deficiency, we first generated Nanog/ ESCs by targeting
the remaining intact Nanog allele of the TNG MKOS
ESCs, from which Nanog null (NanogG/G) MKOS MEFs
could be derived (Figure 6A; Figure S4A). We then induced
expression of MKOS and analyzed ICAM1 and CD44 dy-
namic changes during reprogramming. Surprisingly, we
could only detect a slight delay, if any, in CD44 downregu-
lation but with accelerated Nanog-GFP expression, indi-
cating activation of the Nanog promoter (Figure 6B). The
CFA and Dppa3 and Dppa4 expression of NanogG/G 3NG+
(CD44ICAM1+Nanog-GFP+) cells on day 10 was similar
to that of NanogG/+ 3NG+ cells, indicating that not only
the cell surface markers but also the phenotypic character-
istics are comparable (Figures 6C and S4C). We confirmed
the absence ofNanog expression in theNanogG/G iPSC lines,
as well as pluripotency gene expression (Figures 6D
and 6E). Chimera contribution demonstrated that the
NanogG/G iPSCs were indeed pluripotent (Figure 6F).
NanogG/G MKOS MEFs produced as many Nanog-GFP+ col-
onies as TNG MKOS MEFs, not only in the presence but
also in the absence of VitC (Figures 6G, 6H, and S4B).
Despite displaying slightly increased Nanog-GFP expres-
sion, which could be due to the two Nanog-GFP alleles in
NanogG/G cells and/or lack of the auto-repression by
NANOG protein (Fidalgo et al., 2012; Navarro et al.,
2012), our results demonstrate that there is no clear addi-
tional roadblock inNanognullMKOSMEF reprogramming.
Thus, the previously described Nanog null reprogramming
phenotypes might have been a product of the reprogram-
ming systems used in these studies.
Cassette-Dependent Phenotypes of Nanog Null MEF
Reprogramming
To date, all the reported Nanog/MEF reprogramming ex-
periments have been carried out with the STEMCCA re-
programming cassette or four retroviral vector reprogram-
ming systems (Carter et al., 2014; Schwarz et al., 2014;
Silva et al., 2009), both of which tend to generate a high
proportion of partially reprogrammed cells, unlike MKOS
cassette-mediated reprogramming. To further investigate
whether our ability to efficiently reprogram Nanog/
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MEFs was due to the MKOS reprogramming cassette, we
performed Nanog null MEF reprogramming using PB trans-
posons with various polycistronic cassettes described
earlier. A Nanog null ESC line constitutively expressing
GFP, RCNbH-B(t), was used to obtain Nanog null MEFs
through morula aggregation (Chambers et al., 2007). A
mixture of GFP+ Nanog null and GFP WTMEFs harvested
from chimeric embryos was reprogrammed in the presence
or absence of VitC (Figure 6I). To assess reprogramming ef-
ficiency, cells were stained for DPPA4 after 15 days of doxy-
cycline administration, and relative reprogramming effi-
ciencies of WT and Nanog null MEFs were calculated by
normalizing the DPPA4+ colony numbers by the numbers
of GFPWTandGFP+Nanog nullMEFs on day 0 (Figure 6J).
Even in this primary PB reprogramming setting, the lack of
Nanog did not significantly affect the reprogramming effi-
ciency in either the presence or the absence of VitC when
the MKOS or OSKM cassette was used (Figure 6J). Similarly,
Nanog/MEFs reprogrammed with the OKMS cassette did
not show an evident reduction of iPSC colony formation in
comparison toWTMEFs in the presence of VitC (Figure 6J).
However, the reduction of reprogramming efficiency
became severe in the absence of VitC, ending up to 70%
lower than WT (Figure 6J). Interestingly, the STEMCCA
Figure 5. Klf4L Restores Surface Marker and Nanog-GFP Expression Patterns during Reprogramming
(A) E-CAD upregulation in PB reprogramming with the MKOS, OSKM, OKMS, OK+9MS, STEMCCA, and STEMCCA+9 cassettes.
(B) CD44, ICAM1, and Nanog-GFP expression in MKOS, OSKM, OKMS, OK+9MS, STEMCCA, and STEMCCA+9 reprogramming. Red indicates
Nanog-GFP, and green indicates Nanog-GFP+.
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cassette could not overcome the lack of Nanog even in the
presence of VitC, wherein Nanog null MEFs had 60%–
70% reprogramming efficiency reduction (Figure 6J). Sur-
prisingly, these reduced reprogramming efficiencies of
Nanog/ cells with the OKMS and STEMCCA cassettes
were almost completely or partially rescued with OK+9MS
and STEMCCA+9, respectively (Figure 6J). In summary,
Nanog expression appeared more critical in less efficient re-
programming conditions. Absence of endogenous Nanog
had little impact on reprogramming, either in the presence
or absence of VitC, when more efficient polycistronic re-
programming cassettes with Klf4L were used. Comparing
reprogramming efficiency between WT morula-derived
MEFs and Nanog null ESC-derived MEFs that did not go
through germline may not be a perfect setup. However,
the previous works had taken similar approaches and
concluded that endogenous Nanog was critical for efficient
reprogramming, even though it was not absolutely essen-
tial for the iPSC generation (Carter et al., 2014; Schwarz
et al., 2014). Thus, previous results reporting Nanog impor-
tance in the iPSC generation were probably due to ineffi-
cient and/or less homogenous reprogramming systems,
such as viral delivery of the reprogramming factors or use
of the polycistronic cassette with Klf4S. Notably, addition
of exogenous Nanog expression could increase the reprog-
ramming efficiency in both TNG MKOS and TNG OKMS
reprogramming systems, in agreement with previous ob-
servations in various reprogramming systems (Figures 6K
and S4D) (Hanna et al., 2009; Silva et al., 2009). Therefore,
the molecular mechanisms of reprogramming enhance-
ment both by endogenous Nanog in inefficient reprogram-
ming systems and by exogenous Nanog even in efficient re-
programming systems are of interest.
DISCUSSION
To elucidate the precise molecular mechanisms of reprog-
ramming and improve its efficiency and kinetics, it is
critical to generatemolecular routemaps and identify road-
blocks to regain pluripotency. Several different reprogram-
ming systems have been used for this purpose. In this work,
we have reported that polycistronic reprogramming cas-
settes with the four Yamanaka factors in different orders
have distinct potentials to produce fully reprogrammed
cells as well as cells trapped in partially reprogrammed
states due to distinct severity and/or type of molecular
obstacles.
Reprogramming Routes
Using the MKOS and OKMS cassettes, we have demon-
strated that the pattern of E-CAD, CD44, and ICAM1
expression changes and the gene expression profiles of
the intermediates can vary largely depending on the re-
programming system. Does this mean that cells reach a
pluripotent state through different routes? While PCA
clearly distinguished MKOS from OKMS intermediates
(2NG and 3NG), flow cytometry analysis of the sorted
populations demonstrated that E-CAD+ 3NG was the
major source of Nanog-GFP+ cells in both MKOS OKMS re-
programming. In addition, E-CAD+ 2NG cells gave rise to
E-CAD+ 3NG cells more efficiently than any other inter-
mediates. Therefore, it is likely that, during both MKOS
and OKMS reprogramming, the cells that finally become
iPSCs display the same changes in E-CAD, CD44, and
ICAM1 expression, i.e., transition from E-CAD+ 2NG to
E-CAD+ 3NG before expressing Nanog-GFP. However, the
majority of the reprogramming intermediates in the
OKMS systemwas trapped in partially reprogrammed states
and prevented the identification of cells progressing
toward the iPSC state, concealing critical gene expression
changes during iPSC generation. These data highlight
the importance of using reprogramming systems with less
heterogeneity and high efficiency to characterize the cells
that become iPSCs.
System-Dependent Roadblocks and Dispensability of
Nanog
There are two kinds of gene expression changes during re-
programming: those that are necessary to establish the
pluripotent state and those that do take place but do not
affect the generation of iPSC. Changes of the first group,
which are difficult to achieve and occur at a lower fre-
quency and/or with slower kinetics are considered here as
molecular roadblocks. Upregulation of E-CAD and some
of the transcription factors shown in Figures S2C and S2D
could belong to the first class in OKMS reprogramming sys-
tems. Nanog upregulation clearly belongs to the first group
in OKMS and STEMCCA reprogramming; however, it falls
into the second groupwhenmore efficient reprogramming
cassettes with Klf4L are used. It is likely that cells with
less Klf4 expression depend on Nanog to overcome some
obstacles and establish the pluripotency gene expression
network, while abundant Klf4 is sufficient to compensate
for a lack of Nanog. It is also notable that Nanog/ epiblast
stem cells (EpiSCs) can be reprogrammed more efficiently
by Esrrb overexpression rather thanKlf4 expression (Festuc-
cia et al., 2012), suggesting several alternative routes to
iPSCs. While the indispensability of Nanog for iPSC gener-
ation is system and context dependent, overexpression of
Nanog improved reprogramming efficiency even in the
efficient MKOS reprogramming system. In addition, the
importance of Nanog could potentially be significant in
less efficient reprogramming systems such as human cell
reprogramming. Thus, the roles of Nanog in reprogram-
ming are still of interest.
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Figure 6. Reprogramming Cassette-Dependent Efficient Nanog Null MEF Reprogramming
(A) A strategy for Nanog null TNG MKOS MEF reprogramming. The WT Nanog locus in TNG MKOS ES cells was converted to a Frt floxed allele
via gene targeting, resulting in NanogG/fl ES cells. The remaining Nanog coding sequence was excised by transient expression of FLP,
(legend continued on next page)
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Reprogramming Factor Stoichiometry
The generation of iPSCs is accomplished by forced gene
expression changes resulting from overexpression of
Oct4, Sox2, Klf4 and c-Myc: O, S, K, and M, respectively.
Therefore, it is reasonable that reprogramming efficiencies
and gene expression changes largely depend on expres-
sion levels of each factor and/or the balance of four fac-
tors, i.e., stoichiometry. Replacement of Klf4S with Klf4L
results in higher KLF4 protein level and improved reprog-
ramming efficiency. This made the reprogramming pro-
cess traceable by monitoring CD44 and ICAM1 expression
and diminished Nanog dependency. Consistent with
these findings, it has been recently reported that tran-
scription pause release is a rate-limiting step for iPSC
generation and that KLF4 facilitates the recruitment of
P-TEFb, a positive transcription elongation factor, at the
pluripotency gene loci (Liu et al., 2014). Moreover, the
combined transfection of Klf4 and activated Stat3 was
sufficient to bypass the necessity for Nanog during EpiSCs
reprogramming (Stuart et al., 2014). Our rescue strategy
did not distinguish whether the stoichiometry of the
four factors, the absolute KLF4 levels, or both were critical
for efficient reprogramming. Therefore, future work with
different experimental settings is necessary to address
this point.
Optimal Tools for Mechanistic Analyses
Some polycistronic cassettes, such as MKOS and OSKM,
produce robust reprogramming progression and minimize
generation of partially reprogrammed cells. Therefore, they
are more suited for investigating molecular events impor-
tant for progression toward a pluripotent state. On the
other hand, analysis of partially reprogrammed cell popula-
tions from less efficient reprogramming systems should
provide information on context-dependent roadblocks
and their effects. The impact of distinct reprogramming
cassettes on the reprogramming phenotypes might also
be different depending on cell types, species, culture condi-
tions, gene delivery methods, or possibly even different
expression levels of endogenous Klf4. Overall, our work
highlights the importance of taking into account the re-
programming systems used when investigating the molec-
ular mechanisms of cellular reprogramming.
EXPERIMENTAL PROCEDURES
All animal experiments were approved by the University of Edin-
burgh Animal Welfare and Ethical Review Body, performed at the
University of Edinburgh, and carried out according to regulations
specified by the Home Office and Project License 60/4435.
Cell Culture
MEFs with 129 genetic backgrounds were prepared from embry-
onic-day (E)12.5 embryos as described before (Kaji et al., 2009)
and cultured in MEF medium (Glasgow minimun essential me-
dium [GMEM] supplemented with 10% fetal calf serum [FCS],
penicillin-streptomycin, 13 non-essential amino acids) (Invitro-
gen), 1 mM sodium pyruvate, 2 mM glutamine, 0.05 mM 2-mer-
captoethanol (Life Technologies) supplemented with 5 ng/ml
fibroblast growth factor-2 (FGF2) and 1 ng/ml heparin. ESCs and
resulting in Nanog null MKOS ESCs (NanogG/G). Blue boxes 1–4 indicate exons 1–4. FLP recombination target sites FRT (F) and F3 in the cell
lines are indicated in orange and yellow, respectively.
(B) CD44/ICAM1 expression changes during NanogG/+ (TNG) and NanogG/G (null) MKOS MEF reprogramming. Red indicates Nanog-GFP, and
green indicates Nanog-GFP+.
(C) Nanog-GFP+ CFA of 3NG+ cells sorted on day 10 of NanogG/+ and NanogG/G MKOS MEF reprogramming. Cells were cultured in the presence
of doxycycline for 10 days after the sorting. Error bars represent SD; n = 3 independent experiments. ns, not significant compared to ESCs,
by Student’s t test.
(D) The absence of Nanog protein in NanogG/G MKOS ESCs and NanogG/G iPSC lines was confirmed by western blotting.
(E) qRT-PCR analysis of pluripotency genes in NanogG/G iPSC lines in comparison to a WT ESC line.
(F) Chimeric mice generated with NanogG/G iPSC cell lines.
(G) NanogG/+ and NanogG/G MKOS MEFs were reprogrammed in the presence or absence of VitC (+VitC and -VitC, respectively). Re-
programming efficiency on day 15 was calculated as shown in Figure S2B. Error bars represent SD; n = 4–6 independent experiments.
(H) Whole well images of NanogG/+ and NanogG/G MKOS MEF reprogramming in the presence or absence of VitC (+VitC and -VitC, respec-
tively). Scale bar, 7 mm.
(I) A strategy for Nanog null MEF reprogramming with various reprogramming cassettes with Klf4L (red) or Klf4S (blue). WT and Nanog null
mixed MEFs isolated from E12.5 chimeric embryos, generated with a Nanog null ESC line BT12 constitutively expressing GFP, were re-
programmed via PB transposons. dox, doxycycline.
(J) Numbers of DPPA4+ colonies on day 15 were scored, and reprogramming efficiencies of Nanog null cells against WT cells were shown.
Error bars represent SD; n = 3. **p < 0.01; ***p < 0.001, ns, not significant compared to +VitC or -VitC MKOS reprogramming, respectively,
by Student’s t test.
(K) Increased reprogramming efficiency by Nanog overexpression during TNG MKOS or OKMS reprogramming. Error bars represent SD; n = 3
independent experiments.
See also Figure S2B.
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iPSCs were cultured in ESC medium (MEF medium supplemented
with human LIF [leukemia inhibitory factor], 100 U/ml).
piggyBac Transposon Reprogramming
piggyBac PB-TAP IRI attP2LMKOSimO, PB-TAP IRI 2LOSKMimO, and
PB-TAP IRI tetO-STEMCCAimO have been described previously (dos
Santos et al., 2014; O’Malley et al., 2013). The piggyBac OKMS
reprogramming vector, PB-TAP IRI 2L OKMSimO, was generated
by replacing the OSKM cassette of PB-TAP IRI 2LOSKMimO with
the OKMS cassette (Kim et al., 2015). Replacement of Klf4s with
Klf4L was conducted by using the Gibson assembly. Rosa
rtTA/rtTA,
NanogeGFP/+ MEFs, or MEFs derived from chimeric embryos ge-
nerated with Nanog/ BT12 ESCs were plated in a six-well plate
at 1 3 105 MEFs per well. The following day, the PB transposons
carrying a reprogramming cassette (500 ng) and the CAG-pro-
moter-driven rtTA (500 ng), plus the CMV-promoter-driven-
HyPBase (500 ng) in the case of BT12 ESC-derived Nanog/ MEFs,
were introduced into the MEFs using Fugene HD (Promega) (Yusa
et al., 2011). The cells were cultured in reprogramming medium
for 15–16 days. Plasmid sequences are available upon request.
Tg MEF Reprogramming
TNG MKOS/OKMS and Nanog null MKOS MEFs were isolated
from E12.5 chimeric embryos generated via morula aggregation.
One-tenth of the dissociated cells were exposed to doxycycline
(1,000 ng/ml) for 2 days, and mOrange expression was measured
by flow cytometry to assess the proportion of Tg MEFs. For reprog-
ramming experiments, TgMEFswere diluted to 5%by the addition
of WT MEFs and plated in a gelatinized six-well plate at 1 3 105
cells per well (5,000 Tg MEFs per well). For sorting experiments,
MEFs were plated at 2 3 105 cells per gelatinized 100-mm plate
with 5% Tg MEFs. All reprogramming experiments were carried
out in the aforementioned ESC medium supplemented with
1.0 mg ml1 doxycycline (Sigma) and 10 mg/ml VitC (Sigma) unless
otherwise specified. Medium was changed every 2 days. Whole-
well imaging and quantification of total and GFP+ colony numbers
were performed with the Celigo S Cell Cytometer (Nexcelom).
Overexpression of Nanog during TNG MKOS/OKMS MEF re-
programming was performed with FUW-TetO-Nanog (Addgene
#40800) (Buganim et al., 2012).
Flow Cytometry and Cell Sorting
The following antibodies from eBioscience were used with the
indicated dilution: ICAM1-biotin (13-0541; 1/100), CD44-eFluor
450 (48-0441-82; 1/100), CD44-allophycocyanin (APC) (17-
0441; 1/300), streptavidin-phycoerythrin (PE)-Cy7 (25-4317-82;
1/1500), and E-CADHERIN-eFluor 660 (50-3249-80; 1/200).
Dead cells were excluded using DAPI (Invitrogen, 0.5 ng ml1)
or DRAQ5 (eBioscience, 10 mM) nucleic acid staining. Cells were
treated with 0.25% trypsin and 1 mM EDTA (Life Technologies)
for 1–2 min at 37C, collected in GMEM containing 10% FCS,
and counted. Staining was carried out in FACS (fluorescence-acti-
vated cell sorting) buffer (2% FCS in PBS) for 30 min at 4C, and
followed by washing with FACS buffer, sorting, and/or analysis
with FACSAriaII or LSRFortessa (BD Biosciences). Excitation laser
lines and filters used for each fluorophore are summarized in
Table S1. Data were analyzed using FlowJo software (Tree Star).
For colony formation assays, sorted cells were plated on g-irradi-
ated MEFs in 12-well plates at 1.0–3.0 3 103 cells per well. Nanog-
GFP+ colonies were quantified 10 days after sorting. For time
course analysis of the sorted subpopulation, the cells were plated
on g-irradiated MEFs in 48-well plates at 3 3 104 cells per well. In
both cases, cells were cultured in reprogramming medium after
sorting.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde (PFA) (Sigma) for
10 min; permeabilized with 0.1% Triton X/PBS for 1 hr at room
temperature; blocked with 5% Normal Goat Serum (SouthernBio-
tech), 0.1% Tween 20 in PBS for 1 hr; and stained overnight
with the primary antibody at 4C (1:1,000 in blocking solution)
and 1 hr with the secondary antibodies (1:1,000 in blocking solu-
tion). Anti-mouse NANOG and DPPA4 antibodies were obtained
from eBioscience (14-5761) and Cosmo Bio (CAC-TMD-PB-DP4),
respectively.
Western Blotting
Human embryonic kidney (HEK) cells (2 3 106 cells per 100-mm
plate) were seeded in MEF medium 1 day before transfection.
The following day, cells were transfected using Lipofectamine
2000 (#11668027, Life Technologies) with the PB transposons car-
rying the rtTA and the appropriate cassette (12 mg each). One day
after transfection, the medium was replaced with MEF medium
containing 1,000 ng/ml doxycycline. At 24 hr later, the cells
were harvested and re-suspended in hypotonic buffer (10 mM
HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.2 mM PMSF,
0.5 mM DTT). The swollen cells were lysed with 1% NP-40, and
nuclei were pelleted and then re-suspended in hypertonic buffer
(20 mM HEPES, pH 7.9, 25% glycerol, 1.5 mM MgCl2, 1 M NaCl,
0.2 mM PMSF, 0.5 mM DTT). The extracted soluble nuclear pro-
teins were collected after centrifugation. Protein concentration
was assessed with the Bio-Rad protein assay, and 10 mg of each
sample was used for SDS-PAGE. For the western blotting, rabbit
anti-KLF4 (1:500; sc-20691, Santa Cruz Biotechnology), rabbit
anti-LAMIN B1 (1:1,000; ab16048, Abcam), anti-rabbit immuno-
globulin G-horseradish peroxidase (IgG-HRP) secondary anti-
bodies (1:5,000; Sigma-Aldrich), and the ECL Western Blotting
Detection Kit (GE Healthcare) were used.
Global Gene Expression Analysis
Multiplexed RNA sequencing was performed as described pre-
viously using 10 ng RNA of each sorted subpopulation, and qual-
ity control and alignment to the mouse reference genome
(NCBI37.1/mm9) were performed using the STRT method pipe-
line as previously described (Islam et al., 2011). The heatmaps
were generated using the average of replicates of variance-stabiliz-
ing transformed (VST) gene expression read counts (generated us-
ing the DESeq package in R), and mean-centered per gene. Color
code black (0.00) means that the expression level is equal to the
mean expression levels of all samples (from MEFs to WT ESCs)
of the gene. PCA was performed in R and plotted with the scatter-
plot3d library (Ligges and Maechler, 2003). Cluster overlaps were
plotted using a Circos-generated chord diagram (Krzywinski,
et al., 2009).
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